Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-13-000942
Filing Date
2013-02-19
Accepted
2013-02-19 13:26:35
Documents
11
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 c72710_10q.htm 10-Q 311729
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER c72710_ex31-1.htm EX-31.1 12225
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER c72710_ex31-2.htm EX-31.2 11905
4 CERTIFICATION OF PERIODIC REPORT c72710_ex32-1.htm EX-32.1 6055
5 CERTIFICATION OF PERIODIC REPORT c72710_ex32-2.htm EX-32.2 5850
  Complete submission text file 0000930413-13-000942.txt   2890518

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ibio-20121231.xsd EX-101.SCH 33313
7 XBRL INSTANCE FILE ibio-20121231.xml EX-101.INS 428772
8 XBRL CALCULATION FILE ibio-20121231_cal.xml EX-101.CAL 10730
9 XBRL DEFINITION FILE ibio-20121231_def.xml EX-101.DEF 159761
10 XBRL LABEL FILE ibio-20121231_lab.xml EX-101.LAB 233910
11 XBRL PRESENTATION FILE ibio-20121231_pre.xml EX-101.PRE 164386
Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35023 | Film No.: 13622599
SIC: 2834 Pharmaceutical Preparations